Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose decitabine in Intermediate-1 risk myelodysplastic syndrome
KCT0003414Phase 4Terminated
- Sponsor
- Pusan National University Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of decitabine in myelodysplastic syndrome (MDS), sponsored by Pusan National University Hospital. Started Dec 2018; status: terminated.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on KCT0003414.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003414.